Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study

Overview of attention for article published in Neuropsychiatric Disease and Treatment, August 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 31 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 20 publications that cite this research output.

20

The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.

Ketamine for depressive symptoms: A retrospective chart review of a private ketamine clinic

Article in South African Journal of Psychiatry (February 2024)

Short-term ketamine use in bipolar depression: a review of the evidence for short-term treatment management

Article in Frontiers in Psychiatry (December 2023)

An Update on the Efficacy of Single and Serial Intravenous Ketamine Infusions and Esketamine for Bipolar Depression: A Systematic Review and Meta-Analysis

Article in Brain Sciences (December 2023)